Royalty Pharma plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MORGAN STANLEY | 05/15/2026 | 43.57 M | $2.09 B | -21.17% | 10.09% |
| CAPITAL INTERNATIONAL INVESTORS | 05/13/2026 | 35.01 M | $1.68 B | 12.54% | 8.11% |
| BLACKROCK, INC. | 05/13/2026 | 25.91 M | $1.24 B | -1.07% | 6.00% |
| FMR LLC | 05/15/2026 | 25.15 M | $1.21 B | -4.26% | 5.82% |
| BAILLIE GIFFORD & CO | 05/08/2026 | 16.16 M | $774.99 M | -5.02% | 3.74% |
| SWEDBANK AB | 04/29/2026 | 11.59 M | $555.81 M | -2.98% | 2.68% |
| STATE STREET CORP | 05/15/2026 | 10.99 M | $527.18 M | 3.19% | 2.54% |
| CAPITAL WORLD INVESTORS | 05/13/2026 | 8.04 M | $385.52 M | 100.00% | 1.86% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 7.87 M | $376.52 M | 1.94% | 1.82% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 7.48 M | $358.85 M | -36.28% | 1.73% |
| CALEDONIA (PRIVATE) INVESTMENTS PTY LTD | 05/15/2026 | 7.17 M | $343.87 M | -2.83% | 1.66% |
| 05/15/2026 | 4.53 M | $217.39 M | 100.00% | 1.05% | |
| VICTORY CAPITAL MANAGEMENT INC | 05/15/2026 | 3.85 M | $184.87 M | -24.54% | 0.89% |
| NORTHERN TRUST CORP | 05/14/2026 | 3.81 M | $182.71 M | -4.86% | 0.88% |
| ROYAL LONDON ASSET MANAGEMENT LTD | 05/01/2026 | 3.81 M | $182.69 M | 2,019.48% | 0.88% |
| AQR CAPITAL MANAGEMENT LLC | 05/15/2026 | 3.78 M | $179.65 M | 47.53% | 0.88% |
| INVESCO LTD. | 05/12/2026 | 3.75 M | $180.00 M | 149.80% | 0.87% |
| PATIENT CAPITAL MANAGEMENT, LLC | 05/14/2026 | 3.64 M | $174.79 M | 9.30% | 0.84% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 3.50 M | $167.70 M | 29.05% | 0.81% |
| LEGAL & GENERAL GROUP PLC | 05/08/2026 | 3.36 M | $161.32 M | 8.90% | 0.78% |
| UBS ASSET MANAGEMENT AMERICAS INC | 05/13/2026 | 3.10 M | $148.50 M | -0.74% | 0.72% |
| AMUNDI | 05/18/2026 | 3.09 M | $148.17 M | 15.28% | 0.72% |
| 05/13/2026 | 3.03 M | $13.66 M | 100.00% | 0.70% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 3.03 M | $145.25 M | 3.93% | 0.70% |
| CITADEL ADVISORS LLC | 05/15/2026 | 2.68 M | $128.61 M | -49.16% | 0.62% |
| NEW SOUTH CAPITAL MANAGEMENT INC | 05/13/2026 | 2.63 M | $125.96 M | -10.34% | 0.61% |
| REGAL PARTNERS LTD | 05/15/2026 | 2.62 M | $125.90 M | -0.61% | 0.61% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 2.52 M | $121.01 M | 62.65% | 0.58% |
| DEUTSCHE BANK AG\ | 05/06/2026 | 2.45 M | $117.68 M | 12.28% | 0.57% |
| JANE STREET GROUP, LLC | 05/12/2026 | 2.40 M | $115.15 M | -51.48% | 0.56% |
| DORSEY ASSET MANAGEMENT, LLC | 05/15/2026 | 2.28 M | $109.21 M | 0.76% | 0.53% |
| 05/08/2026 | 2.27 M | $108.83 M | 100.00% | 0.53% | |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 2.25 M | $108.01 M | 230.50% | 0.52% |
| MARSHALL WACE, LLP | 05/15/2026 | 2.12 M | $101.73 M | 434.53% | 0.49% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 2.04 M | $97.99 M | 100.00% | 0.47% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 05/14/2026 | 2.01 M | $96.44 M | -39.32% | 0.47% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 1.93 M | $92.79 M | 56.82% | 0.45% |
| UBS GROUP AG | 05/05/2026 | 1.81 M | $86.93 M | -9.65% | 0.42% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 1.72 M | $82.42 M | 153.61% | 0.40% |
| JPMORGAN CHASE & CO | 05/13/2026 | 1.68 M | $77.89 M | 10.61% | 0.39% |
| HOMESTEAD ADVISERS CORP | 05/08/2026 | 1.65 M | $78.91 M | -1.11% | 0.38% |
| CLARK CAPITAL MANAGEMENT GROUP, INC. | 05/15/2026 | 1.64 M | $78.67 M | -6.49% | 0.38% |
| HSBC HOLDINGS PLC | 04/30/2026 | 1.54 M | $74.00 M | 2,562.19% | 0.36% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2026 | 1.52 M | $73.13 M | -38.26% | 0.35% |
| RAYMOND JAMES FINANCIAL INC | 05/14/2026 | 1.52 M | $72.69 M | 3.84% | 0.35% |
| MITSUBISHI UFJ TRUST & BANKING CORP | 05/12/2026 | 1.49 M | $71.69 M | -15.29% | 0.35% |
| RUSSELL INVESTMENTS GROUP, LTD. | 05/08/2026 | 1.40 M | $66.81 M | -0.07% | 0.32% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 1.35 M | $64.74 M | -13.28% | 0.31% |
| EVENTIDE ASSET MANAGEMENT, LLC | 05/15/2026 | 1.31 M | $62.60 M | 1.21% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 05/05/2026 | 1.30 M | $62.46 M | -2.81% | 0.30% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Royalty Pharma plc institutional Ownership - FAQ's
During the previous two years, 671 institutional investors and hedge funds held shares of Royalty Pharma plc. The most heavily invested institutionals were:
MORGAN STANLEY: 43.57 M
Capital International Investors: 35.01 M
BlackRock, Inc.: 25.91 M
FMR LLC: 25.15 M
BAILLIE GIFFORD & CO: 16.16 M
Swedbank AB: 11.59 M
82.80% of Royalty Pharma plc stock is owned by institutional investors.
Institutional investors have bought a total of 398.16 M shares in the last 24 months. This purchase volume represents approximately $18.25 B in transactions.